Cargando…

Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine

A 41-year-old male patient was admitted to our hospital due to massive proteinuria and hematuria. His 24-hour urinary protein excretion and the number of urinary erythrocytes were 3.91 g/day and 50–99/high-power field, respectively. A renal biopsy showed a severe pathological pattern of immunoglobul...

Descripción completa

Detalles Bibliográficos
Autores principales: Okonogi, Hideo, Kawamura, Tetsuya, Matsuo, Nanae, Takahashi, Yasuto, Yamamoto, Izumi, Yoshida, Hiraku, Koike, Kentaro, Yokoo, Takashi, Joh, Kensuke, Utsunomiya, Yasunori, Hanaoka, Kazushige, Hosoya, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482084/
https://www.ncbi.nlm.nih.gov/pubmed/23197956
http://dx.doi.org/10.1159/000339401
_version_ 1782247832241045504
author Okonogi, Hideo
Kawamura, Tetsuya
Matsuo, Nanae
Takahashi, Yasuto
Yamamoto, Izumi
Yoshida, Hiraku
Koike, Kentaro
Yokoo, Takashi
Joh, Kensuke
Utsunomiya, Yasunori
Hanaoka, Kazushige
Hosoya, Tatsuo
author_facet Okonogi, Hideo
Kawamura, Tetsuya
Matsuo, Nanae
Takahashi, Yasuto
Yamamoto, Izumi
Yoshida, Hiraku
Koike, Kentaro
Yokoo, Takashi
Joh, Kensuke
Utsunomiya, Yasunori
Hanaoka, Kazushige
Hosoya, Tatsuo
author_sort Okonogi, Hideo
collection PubMed
description A 41-year-old male patient was admitted to our hospital due to massive proteinuria and hematuria. His 24-hour urinary protein excretion and the number of urinary erythrocytes were 3.91 g/day and 50–99/high-power field, respectively. A renal biopsy showed a severe pathological pattern of immunoglobulin A nephropathy (IgAN) that involved marked endocapillary proliferation and segmental sclerosis (Oxford-MEST score: M0, E1, S1, T0). Because he had nephrotic-level proteinuria with severe pathological findings, which are tonsillectomy and corticosteroid pulse therapy-resistant characteristics, he received mizoribine for a long period as part of the combination therapy using corticosteroid, tonsillectomy, dipyridamole, warfarin and renin-angiotensin-aldosterone system blockers. Twelve months after the beginning of treatment, his urinary findings were normal. In this report, we describe the pathological findings and successful treatment course, and discuss the potential effects of long-term coadministration of mizoribine for adult IgAN treatment.
format Online
Article
Text
id pubmed-3482084
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-34820842012-11-29 Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine Okonogi, Hideo Kawamura, Tetsuya Matsuo, Nanae Takahashi, Yasuto Yamamoto, Izumi Yoshida, Hiraku Koike, Kentaro Yokoo, Takashi Joh, Kensuke Utsunomiya, Yasunori Hanaoka, Kazushige Hosoya, Tatsuo Case Rep Nephrol Urol Published: June, 2012 A 41-year-old male patient was admitted to our hospital due to massive proteinuria and hematuria. His 24-hour urinary protein excretion and the number of urinary erythrocytes were 3.91 g/day and 50–99/high-power field, respectively. A renal biopsy showed a severe pathological pattern of immunoglobulin A nephropathy (IgAN) that involved marked endocapillary proliferation and segmental sclerosis (Oxford-MEST score: M0, E1, S1, T0). Because he had nephrotic-level proteinuria with severe pathological findings, which are tonsillectomy and corticosteroid pulse therapy-resistant characteristics, he received mizoribine for a long period as part of the combination therapy using corticosteroid, tonsillectomy, dipyridamole, warfarin and renin-angiotensin-aldosterone system blockers. Twelve months after the beginning of treatment, his urinary findings were normal. In this report, we describe the pathological findings and successful treatment course, and discuss the potential effects of long-term coadministration of mizoribine for adult IgAN treatment. S. Karger AG 2012-06-05 /pmc/articles/PMC3482084/ /pubmed/23197956 http://dx.doi.org/10.1159/000339401 Text en Copyright © 2012 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: June, 2012
Okonogi, Hideo
Kawamura, Tetsuya
Matsuo, Nanae
Takahashi, Yasuto
Yamamoto, Izumi
Yoshida, Hiraku
Koike, Kentaro
Yokoo, Takashi
Joh, Kensuke
Utsunomiya, Yasunori
Hanaoka, Kazushige
Hosoya, Tatsuo
Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine
title Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine
title_full Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine
title_fullStr Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine
title_full_unstemmed Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine
title_short Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine
title_sort successful treatment of adult iga nephropathy with nephrotic-level proteinuria by combination therapy including long-term coadministration of mizoribine
topic Published: June, 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482084/
https://www.ncbi.nlm.nih.gov/pubmed/23197956
http://dx.doi.org/10.1159/000339401
work_keys_str_mv AT okonogihideo successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine
AT kawamuratetsuya successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine
AT matsuonanae successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine
AT takahashiyasuto successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine
AT yamamotoizumi successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine
AT yoshidahiraku successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine
AT koikekentaro successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine
AT yokootakashi successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine
AT johkensuke successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine
AT utsunomiyayasunori successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine
AT hanaokakazushige successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine
AT hosoyatatsuo successfultreatmentofadultiganephropathywithnephroticlevelproteinuriabycombinationtherapyincludinglongtermcoadministrationofmizoribine